<DOC>
	<DOCNO>NCT02835586</DOCNO>
	<brief_summary>It pilot study evaluate feasibility efficiency local delivery paclitaxel stenting long femoropopliteal arterial lesion TASC C D realization large randomize multicentric study . Patients concerned critical ischemia .</brief_summary>
	<brief_title>STREAMER : STent Restenosis And MEdicaments Release</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>patient critical ischemia lower limb ankle pressure &lt; 50 mmHg lesion TASC C D superficial femoral popliteal artery patient allergic paclitaxel patient cancer , neutropenia , immunosuppressor medicament chemotherapy patient contraindication take 2 antiaggregants platelet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>paclitaxel</keyword>
	<keyword>critical ischemia</keyword>
	<keyword>restenosis</keyword>
	<keyword>femoropopliteal artery lesion TASC C D</keyword>
</DOC>